SCHEMBL2213640

SCHEMBL2213640

COc1cc(C=C(C(=O)O)C(=O)O)ccc1O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.77
GLO1 Q04760 4/20 0.68
ABL1 P00519 1/20 0.68
IKBKB O14920 1/20 0.63
CHUK O15111 1/20 0.63
IKBKG Q9Y6K9 1/20 0.63
SNCA P37840 4/20 0.62
KDM4E B2RXH2 2/20 0.62
CA12 O43570 2/20 0.62
CA1 P00915 2/20 0.62
CA2 P00918 2/20 0.62
CA3 P07451 2/20 0.62
PKM P14618 2/20 0.62
CA4 P22748 2/20 0.62
CA6 P23280 2/20 0.62
CA5A P35218 2/20 0.62
CA7 P43166 2/20 0.62
CA9 Q16790 2/20 0.62
CA14 Q9ULX7 2/20 0.62
CA5B Q9Y2D0 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5597360 0.92 MAPT (0.85) MAPTGLO1ABL1IKBKBCHUK
SCHEMBL2252350 0.92 MAPT (0.85) MAPTGLO1ABL1IKBKBCHUK
SCHEMBL12394170 0.92 MAPT (0.85) MAPTGLO1ABL1IKBKBCHUK
SCHEMBL5597202 0.91 MAPT (0.68) MAPTGLO1ABL1IKBKBCHUK
SCHEMBL5597289 0.91 MAPT (0.68) MAPTGLO1ABL1IKBKBCHUK
SCHEMBL5597288 0.91 MAPT (0.68) MAPTGLO1ABL1IKBKBCHUK
SCHEMBL26451545 0.90 MAPT (0.67) MAPTGLO1ABL1IKBKBCHUK
SCHEMBL2903209 0.88 MAPT (0.65) MAPTGLO1ABL1IKBKBCHUK
SCHEMBL5686171 0.87 MAPT (0.68) MAPTGLO1ABL1IKBKBCHUK
SCHEMBL7585369 0.87 GLO1 (0.87) MAPTGLO1ABL1IKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1952843-B1 Photostable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom MERCK PATENT GMBH (DE) 2011-07-27 EP claimed
JP-2007502314-A 2007-02-08 JP claimed
US-20070010579-A1 Copper salts of organic acids and use thereof as fungicides ISARGO S.P.A. (IT) 2007-01-11 US claimed
EP-1633190-A1 COPPER SALTS OF ORGANIC ACIDS AND USE THEREOF AS FUNGICIDES ISAGRO S.p.A. (IT) 2006-03-15 EP claimed
WO-2004103074-A1 COPPER SALTS OF ORGANIC ACIDS AND USE THEREOF AS FUNGICIDES ISAGRO S.P.A. (IT) 2004-12-02 WO claimed
US-20020174491-A1 Process for stabilizing the whiteness of lignin-containing fibrous materials, stabilizer composition and fibrous materials stabilized with this DEGUSSA-AG (DE) 2002-11-28 US claimed
US-11891496-B2 Cyanoacrylate composition with hazardless stabilizer H.B. FULLER COMPANY (US) 2024-02-06 US disclosed
EP-4301793-A1 CYANOACRYLATE COMPOSITION WITH HAZARDLESS STABILIZER H.B. Fuller Company (US) 2024-01-10 EP disclosed
CN-103874687-A Benzodioxepin-3-one compounds as dyes or as fluorescent emitters MERCK PATENT GMBH 2014-06-18 CN disclosed
CN-103370312-A 1,3-dioxan-5-one compounds MERCK PATENT GMBH 2013-10-23 CN disclosed
US-20070010579-A1 Copper salts of organic acids and use thereof as fungicides ISARGO S.P.A. (IT) 2007-01-11 US disclosed
EP-1633190-A1 COPPER SALTS OF ORGANIC ACIDS AND USE THEREOF AS FUNGICIDES ISAGRO S.p.A. (IT) 2006-03-15 EP disclosed
WO-2004103074-A1 COPPER SALTS OF ORGANIC ACIDS AND USE THEREOF AS FUNGICIDES ISAGRO S.P.A. (IT) 2004-12-02 WO disclosed
US-4193926-A 4-(Polyalkoxy phenyl)-2-pyrrolidones SCHERING AKTIENGESELLSCHAFT (DE) 1980-03-18 US disclosed
US-4153713-A NEUROPSYCHOTROPIC AGENTS SCHERING AKTIENGESELLSCHAFT (DE) 1979-05-08 US disclosed
US-4012495-A USED IN TREATING NEUROLOGICAL AND PSYCHIC DISORDERS SCHERING AKTIENGESELLSCHAFT (DT) 1977-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010579-A1 Copper salts of organic acids and use thereof as fungicides AOC3, AOC2, AOC1 MAPT 679/4885GLO1 279/4885ABL1 686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.